Evidence map›Paper›PMID 41535036›Full record

ArticleInternal medicine (Tokyo, Japan)2026

Eosinophilic Granulomatosis with Polyangiitis Complicated by Eosinophilic Chronic Rhinosinusitis Successfully Treated with Combination of Mepolizumab and Dupilumab.

Hirotake Inomata, Noboru Kitamura, Shinya Asatani, Masashi Uchikawa, Kiichi Sugito, Masahiro Nishihara, Kumiko Akiya, Miho Oshima, Hideki Nakamura

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hirotake InomataDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan.
Noboru KitamuraDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan.
Shinya AsataniDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan.
Masashi UchikawaDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan.
Kiichi SugitoDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan.
Masahiro NishiharaDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan.
Kumiko AkiyaDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan.
Miho OshimaDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan.
Hideki NakamuraDivision of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 50-year-old man with a history of bronchial asthma was admitted to our hospital with peripheral neuropathy, sinusitis, and eosinophilia. The patient was diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA). The symptoms partially improved with a combination of prednisolone and mepolizumab. However, nasal mucosal biopsy revealed a complication due to eosinophilic sinusitis. The addition of dupilumab resulted in the improvement of sinusitis. Few reports exist on the combination of these two drugs for EGPA, and no case reports exist on the addition of dupilumab in patients with residual eosinophilic sinusitis after treatment with prednisolone and mepolizumab. This case is valuable for future consideration in cases involving combination therapy.

Indexed as

Antibodies, Monoclonal, HumanizedChurg-Strauss SyndromeEosinophiliaGranulomatosis with PolyangiitisRhinosinusitisSinusitisChronic DiseaseDrug Therapy, CombinationHumansMaleMiddle AgedTreatment OutcomeAntibodies, Monoclonal, Humanizeddupilumabmepolizumabdupilumabeosinophilic chronic rhinosinusitiseosinophilic granulomatosis with polyangiitismepolizumab

Identifiers

PMID41535036
PMCPMC13561548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.